(Q46734418)

English

Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

endometrial cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Susanne C J P Gielen

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

Curt W Burger

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

Liesbeth C M Kühne

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

Payman Hanifi-Moghaddam

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

Leen J Blok

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

publication date

1 October 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

Reproductive Sciences

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

12

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

e55-67

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

The place of chemotherapy in the treatment of early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Endocrine approaches for the treatment of early and advanced breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Aromatase inhibitors in relation to other forms of endocrine therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Connections and regulation of the human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Molecular determinants for the tissue specificity of SERMs

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Progestogenic effects of tibolone on human endometrial cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Molecular cloning and endometrial expression of porcine amphiregulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2005.08.003

21 January 2018

Identifiers

10.1016/J.JSGI.2005.08.003

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16202921

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46734418&oldid=2129034894"